Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid in Acute Viral Hepatitis
NCT07525401Not yet recruiting
- Sponsor
- Combined Military Hospital
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
01
Overview
Open-label trial of ursodeoxycholic acid in Acute Viral Hepatitis (AVH) (2 arms), sponsored by Combined Military Hospital. Primary endpoint: Change in serum total bilirubin levels at 7 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
Acute Viral Hepatitis (AVH)
Beyond the preview
Go deeper on NCT07525401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525401.